company background image
002788 logo

Luyan PharmaLtd SZSE:002788 Stock Report

Last Price


Market Cap







21 Jul, 2024


Company Financials

Luyan Pharma Co.,Ltd.

SZSE:002788 Stock Report

Market Cap: CN¥2.9b

002788 Stock Overview

Engages in the research and development, production, and sale of human health products in China.

002788 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance4/6
Financial Health5/6

Luyan Pharma Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Luyan PharmaLtd
Historical stock prices
Current Share PriceCN¥7.53
52 Week HighCN¥10.19
52 Week LowCN¥6.10
11 Month Change-5.04%
3 Month Change-12.24%
1 Year Change-19.98%
33 Year Change2.31%
5 Year Change-2.84%
Change since IPO-28.51%

Recent News & Updates

Recent updates

Shareholder Returns

002788CN HealthcareCN Market

Return vs Industry: 002788 exceeded the CN Healthcare industry which returned -35.1% over the past year.

Return vs Market: 002788 underperformed the CN Market which returned -16.6% over the past year.

Price Volatility

Is 002788's price volatile compared to industry and market?
002788 volatility
002788 Average Weekly Movement3.9%
Healthcare Industry Average Movement5.2%
Market Average Movement5.9%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 002788 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002788's weekly volatility (4%) has been stable over the past year.

About the Company


Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores.

Luyan Pharma Co.,Ltd. Fundamentals Summary

How do Luyan PharmaLtd's earnings and revenue compare to its market cap?
002788 fundamental statistics
Market capCN¥2.93b
Earnings (TTM)CN¥367.45m
Revenue (TTM)CN¥20.14b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002788 income statement (TTM)
Cost of RevenueCN¥18.62b
Gross ProfitCN¥1.52b
Other ExpensesCN¥1.15b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 22, 2024

Earnings per share (EPS)0.95
Gross Margin7.56%
Net Profit Margin1.82%
Debt/Equity Ratio162.3%

How did 002788 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.